363 related articles for article (PubMed ID: 34716119)
1. Epidemiology and Prevention of Prostate Cancer.
Gandaglia G; Leni R; Bray F; Fleshner N; Freedland SJ; Kibel A; Stattin P; Van Poppel H; La Vecchia C
Eur Urol Oncol; 2021 Dec; 4(6):877-892. PubMed ID: 34716119
[TBL] [Abstract][Full Text] [Related]
2. Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology.
Campi R; Brookman-May SD; Subiela Henríquez JD; Akdoğan B; Brausi M; Klatte T; Langenhuijsen JF; Linares-Espinos E; Marszalek M; Roupret M; Stief CG; Volpe A; Minervini A; Rodriguez-Faba O
Eur Urol Focus; 2019 Nov; 5(6):1029-1057. PubMed ID: 29661588
[TBL] [Abstract][Full Text] [Related]
3. 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review.
Bergengren O; Pekala KR; Matsoukas K; Fainberg J; Mungovan SF; Bratt O; Bray F; Brawley O; Luckenbaugh AN; Mucci L; Morgan TM; Carlsson SV
Eur Urol; 2023 Aug; 84(2):191-206. PubMed ID: 37202314
[TBL] [Abstract][Full Text] [Related]
4. Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic Review of the Literature by the European Association of Urology Section of Oncological Urology (ESOU).
Brookman-May SD; Campi R; Henríquez JDS; Klatte T; Langenhuijsen JF; Brausi M; Linares-Espinós E; Volpe A; Marszalek M; Akdogan B; Roll C; Stief CG; Rodriguez-Faba O; Minervini A
Eur Urol Focus; 2019 Sep; 5(5):756-787. PubMed ID: 29576530
[TBL] [Abstract][Full Text] [Related]
5. International variation in prostate cancer incidence and mortality rates.
Center MM; Jemal A; Lortet-Tieulent J; Ward E; Ferlay J; Brawley O; Bray F
Eur Urol; 2012 Jun; 61(6):1079-92. PubMed ID: 22424666
[TBL] [Abstract][Full Text] [Related]
6. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates.
Culp MB; Soerjomataram I; Efstathiou JA; Bray F; Jemal A
Eur Urol; 2020 Jan; 77(1):38-52. PubMed ID: 31493960
[TBL] [Abstract][Full Text] [Related]
7. The Current Burden of Oropharyngeal Cancer: A Global Assessment Based on GLOBOCAN 2020.
Lorenzoni V; Chaturvedi AK; Vignat J; Laversanne M; Bray F; Vaccarella S
Cancer Epidemiol Biomarkers Prev; 2022 Nov; 31(11):2054-2062. PubMed ID: 36173880
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies.
Islami F; Moreira DM; Boffetta P; Freedland SJ
Eur Urol; 2014 Dec; 66(6):1054-64. PubMed ID: 25242554
[TBL] [Abstract][Full Text] [Related]
9. Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries.
Wong MC; Goggins WB; Wang HH; Fung FD; Leung C; Wong SY; Ng CF; Sung JJ
Eur Urol; 2016 Nov; 70(5):862-874. PubMed ID: 27289567
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends.
Huang J; Chan SC; Lok V; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS;
Lancet Haematol; 2022 Sep; 9(9):e670-e677. PubMed ID: 35843248
[TBL] [Abstract][Full Text] [Related]
12. Global Burden of Urologic Cancers, 1990-2013.
Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
[TBL] [Abstract][Full Text] [Related]
13. Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis.
Benke IN; Leitzmann MF; Behrens G; Schmid D
Ann Oncol; 2018 May; 29(5):1154-1179. PubMed ID: 29788165
[TBL] [Abstract][Full Text] [Related]
14. Burden of esophageal cancer between 2010 and 2019 in Asian countries by geographical region and sociodemographic index: A comparison with global data.
Mazidimoradi A; Amiri S; Khani Y; Allahqoli L; Salehiniya H
Thorac Cancer; 2023 Aug; 14(24):2361-2407. PubMed ID: 37455657
[TBL] [Abstract][Full Text] [Related]
15. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
16. Global patterns of non-Hodgkin lymphoma in 2020.
Mafra A; Laversanne M; Gospodarowicz M; Klinger P; De Paula Silva N; Piñeros M; Steliarova-Foucher E; Bray F; Znaor A
Int J Cancer; 2022 Nov; 151(9):1474-1481. PubMed ID: 35695282
[TBL] [Abstract][Full Text] [Related]
17. International variations in bladder cancer incidence and mortality.
Chavan S; Bray F; Lortet-Tieulent J; Goodman M; Jemal A
Eur Urol; 2014 Jul; 66(1):59-73. PubMed ID: 24451595
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Cancer incidence and mortality and risk factors in member countries of the " Belt and Road " initiative.
Wang B; He F; Hu Y; Wang Q; Wang D; Sha Y; Wu J
BMC Cancer; 2022 May; 22(1):582. PubMed ID: 35614399
[TBL] [Abstract][Full Text] [Related]
20. Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel.
Mahal BA; Gerke T; Awasthi S; Soule HR; Simons JW; Miyahira A; Halabi S; George D; Platz EA; Mucci L; Yamoah K
Eur Urol Oncol; 2022 Feb; 5(1):18-29. PubMed ID: 34446369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
